Northwest Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,797
Closed -$231K 174
2024
Q1
$231K Buy
+1,797
New +$214K 0.06% 151

Other funds holding NVO

Northwest Wealth Management's NVO Position: Q2 2024 in Review

Northwest Wealth Management sold out of Novo Nordisk (NVO) in Q2 2024, closing a stake of 1,797 shares — an estimated $231K sold.

Northwest Wealth Management first reported a position in NVO in Q1 2024 and held it in 1 quarter. The position peaked at $231K in Q1 2024. 1,861 funds tracked by Wall St. Rank hold NVO as of Q2 2024.

  • Northwest Wealth Management reported no remaining Novo Nordisk position as of Q2 2024 after selling out during the quarter.
  • Northwest Wealth Management sold 1,797 Novo Nordisk shares in Q2 2024, an estimated $231K.
  • Northwest Wealth Management first reported a position in Novo Nordisk in Q1 2024 and held it in 1 quarter.
  • Northwest Wealth Management's Novo Nordisk position peaked at $231K in Q1 2024.
  • 1,861 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2024.

Based on Northwest Wealth Management's 13F filing for Q2 2024, filed 5 Aug 2024.